Innovata has entered into a second agreement in which the
development of a combination asthma therapy could generate in
excess of £25 million (€37 million) in milestones and development
funding.
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
Accelovance has broadened its presence in China and expanded its
capacity for conducting Phase I-IV clinical trials for Western
pharmaceutical and biotech firms seeking to enter the Chinese
market, by opening a new office in Shanghai.
Escalating drug costs could be driven down by up to $20 billion a
year and dwindling drug pipelines improved if a newly-formed US
research group is successful.
A Strategic Research Agenda (SRA) was launched last week in a move
to bolster the chemistry and biotechnology industry's contribution
to European growth and competitiveness.
Private equity firm, Direct Capital has acquired a shareholding of
51 per cent in New Zealand Pharmaceuticals (NZP). The investment by
Direct Capital aims to tap into the growing potential of
glycotherapeutics drugs.
Patheon has received the 2005 Contract Manufacturing Company of the
Year Award from consultancy firm Frost & Sullivan, in
recognition of its customer service and innovative market growth
strategies.
The Pharmaceutical Fine Chemicals Business of Clariant took the
opportunity to review new developments at the CPhI Expo in Madrid,
Spain, making announcements on new investments in facilities in
Europe and the US as well as new business...
Pliva released its financial results for the first nine months of
2005, which revealed a net loss of $34 million, as the drug maker
tries to recover from its loss-making drug launch in the US. This
is despite posting higher revenues...
Dr. Reddy's Laboratories (DRL) has signed a definitive agreement to
acquire Roche's Mexican API business, in a move to drive the next
wave of growth in its custom pharmaceutical services (CPS)
business.
Cook Pharmica will be the first contract manufacturer to offer live
webcam services, an innovation that will enable both customers and
regulatory agencies to view production as it occurs.
Lanxess has said it will spin-off its Fine Chemicals operations
into a separate business unit that is expected to become
independent as of the second quarter next year.
New findings may have significant implications for the growing
generics drugs industry, by challenging previous assumptions that
all formulations of the same active pharmaceutical ingredient (API)
are therapeutically equivalent.
Fisher Scientific International reported it's third quarter
performance for 2005, which revealed profit had more than doubled
as a result of improved sales and fewer acquisition related
charges.
AssurX have launched a software process for document control, which
will enable pharmaceutical manufacturing companies to streamline
their approach to monitoring safety issues and overall quality
control efforts.
